A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia. - Zeng, Yunxin; Zhang, Xinyu; Lin, Dongjun; Feng, Xiaohui; Liu, Yuye; Fang, Zhengwen; Zhang, Weijian; Chen, Yu; Zhao, Meng; Wu, Jun; Jiang, Linjia (Journal of Hematology & Oncology, 2021)